SOX5
Basic information
Region (hg38): 12:23529504-24562544
Links
Phenotypes
GenCC
Source:
- Lamb-Shaffer syndrome (Strong), mode of inheritance: AD
- developmental and speech delay due to SOX5 deficiency (Supportive), mode of inheritance: AD
- Lamb-Shaffer syndrome (Definitive), mode of inheritance: AD
- Lamb-Shaffer syndrome (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lamb-Shaffer syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 22290657; 23220431; 23498568; 26111154 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (119 variants)
- Lamb-Shaffer_syndrome (94 variants)
- Inborn_genetic_diseases (69 variants)
- SOX5-related_disorder (16 variants)
- not_specified (7 variants)
- Intellectual_disability (5 variants)
- Generalized_hypotonia (2 variants)
- Epileptic_encephalopathy (1 variants)
- Strabismus (1 variants)
- Cerebral_visual_impairment_and_intellectual_disability (1 variants)
- Tourette_syndrome (1 variants)
- Autism_spectrum_disorder (1 variants)
- Neurodevelopmental_delay (1 variants)
- Thoracolumbar_scoliosis (1 variants)
- Aplasia/Hypoplasia_of_the_nails (1 variants)
- See_cases (1 variants)
- Severe_global_developmental_delay (1 variants)
- Central_hypotonia (1 variants)
- Congenital_anomaly_of_kidney_and_urinary_tract (1 variants)
- Developmental_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SOX5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006940.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 20 | 27 | ||||
missense | 19 | 130 | 17 | 171 | ||
nonsense | 17 | 23 | ||||
start loss | 1 | 1 | ||||
frameshift | 14 | 21 | ||||
splice donor/acceptor (+/-2bp) | 10 | 15 | ||||
Total | 46 | 34 | 136 | 38 | 4 |
Highest pathogenic variant AF is 0.00000657358
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SOX5 | protein_coding | protein_coding | ENST00000451604 | 15 | 421527 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000510 | 125741 | 0 | 4 | 125745 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.15 | 244 | 427 | 0.571 | 0.0000232 | 5018 |
Missense in Polyphen | 77 | 214.81 | 0.35845 | 2495 | ||
Synonymous | -0.210 | 159 | 156 | 1.02 | 0.00000852 | 1478 |
Loss of Function | 5.52 | 3 | 41.2 | 0.0728 | 0.00000215 | 458 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000883 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds specifically to the DNA sequence 5'-AACAAT-3'. Activates transcription of COL2A1 and AGC1 in vitro.;
- Disease
- DISEASE: Lamb-Shaffer syndrome (LAMSHF) [MIM:616803]: An autosomal dominant, neurodevelopmental disorder characterized by global developmental delay, intellectual disability, language and motor impairment, and distinct facial features. Additional variable skeletal abnormalities may also be present. {ECO:0000269|PubMed:22290657, ECO:0000269|PubMed:23220431, ECO:0000269|PubMed:23498568, ECO:0000269|PubMed:26111154}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Neural Crest Differentiation;Endochondral Ossification
(Consensus)
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- loftool
- 0.0509
- rvis_EVS
- -0.96
- rvis_percentile_EVS
- 9.09
Haploinsufficiency Scores
- pHI
- 0.631
- hipred
- Y
- hipred_score
- 0.809
- ghis
- 0.605
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.804
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sox5
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; respiratory system phenotype; skeleton phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype;
Gene ontology
- Biological process
- transcription by RNA polymerase II;positive regulation of chondrocyte differentiation;cell fate commitment;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;asymmetric neuroblast division;positive regulation of cartilage development;cellular response to transforming growth factor beta stimulus;positive regulation of mesenchymal stem cell differentiation
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding